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Method
High-throughput discovery of rare insertions
and deletions in large cohorts
Francesco L.M. Vallania, Todd E. Druley, Enrique Ramos, Jue Wang, Ingrid Borecki,
Michael Province, and Robi D. Mitra1
Center for Genome Sciences and Systems Biology Department of Genetics Washington University in St. Louis School of Medicine,
St. Louis, Missouri 63108, USA
Pooled-DNA sequencing strategies enable fast, accurate, and cost-effect detection of rare variants, but current approaches
are not able to accurately identify short insertions and deletions (indels), despite their pivotal role in genetic disease.
Furthermore, the sensitivity and specificity of these methods depend on arbitrary, user-selected significance thresholds,
whose optimal values change from experiment to experiment. Here, we present a combined experimental and compu-
tational strategy that combines a synthetically engineered DNA library inserted in each run and a new computational
approach named SPLINTER that detects and quantifies short indels and substitutions in large pools. SPLINTER integrates
information from the synthetic library to select the optimal significance thresholds for every experiment. We show that
SPLINTER detects indels (up to 4 bp) and substitutions in large pools with high sensitivity and specificity, accurately
quantifies variant frequency (r = 0.999), and compares favorably with existing algorithms for the analysis of pooled
sequencing data. We applied our approach to analyze a cohort of 1152 individuals, identifying 48 variants and validating 14
of 14 (100%) predictions by individual genotyping. Thus, our strategy provides a novel and sensitive method that will
speed the discovery of novel disease-causing rare variants.
[Supplemental material is available online at www.genome.org. Sequencing data is available at http://cgs.wustl.edu/
~fvallania/4_splinter_2010/5_splinter_webpage/SPLINTER_supporting_material.html. Novel SNP data have been sub-
mitted to the NCBI dbSNP (http://www.ncbi.nlm.nih.gov/snp) under accession nos. rs113740468, rs78985299, and
rs113225202. SPLINTER is available at http://www.ibridgenetwork.org/wustl/splinter.]
Understanding the genetic basis of common diseases is an impor-
tant step toward the goal of personalized medicine (Ng et al. 2008).
At present, two distinct hypotheses are under debate (Goldstein
2009; Manolio et al. 2009). The common variant, common disease
(CVCD) hypothesis states that disease-causing alleles are common
in the human population (frequency > 5%) (Reich and Lander
2001). In contrast, the rare variant, common disease (RVCD) hy-
pothesis posits that multiple disease-causing alleles, which in-
dividually occur at low frequencies (<<1%), cumulatively explain
a large portion of disease susceptibility (Cohen et al. 2004; Ji et al.
2008). Recent evidence favors the RVCD hypothesis, as common
variants have failed to explainmany complex traits (Manolio et al.
2009), while rare genetic variants have been successfully associated
with HDL levels (Cohen et al. 2004), blood pressure ( Ji et al. 2008),
obesity (Ahituv et al. 2007), and colorectal cancer (Fearnhead et al.
2004, 2005).
Due to their low frequencies, identifying rare, disease-associated
variants requires genotyping large cohorts in order to reach the
appropriate statistical power (e.g., 5000 individuals are required to
detect mutations present at 0.1% in the population with a proba-
bility of 96%). ‘‘Collapsing’’ methods in which rare variants are
grouped together before associationwith disease have been shown
to improve statistical power (Li and Leal 2008), but analysis of
large cohorts is still required. One recent strategy for genotyping
large cohorts consists of pooled-sample sequencing, where indi-
vidual samples are pooled prior to analysis on a next-generation
sequencing platform (Van Tassel et al. 2008; Druley et al. 2009;
Erlich et al. 2009; Koboldt et al. 2009; Prabhu and Pe’er 2009).
By leveraging the massively parallel output of second-generation
DNA sequencing, pooled-sample sequencing allows fast and ac-
curate detection of rare variants in thousands of samples at a
fraction of time and cost of traditionalmethods. Individual sample
identities can be recovered using a combinatorial pooling strategy
(such as DNA Sudoku) (Erlich et al. 2009).
Despite the promise of this method for studying rare genetic
variants, current computational approaches pose a bottleneck be-
cause they are focused either on single individual genotyping (Li
et al. 2008) or on the detection of common variants in small-sized
pools (Koboldt et al. 2009). Our previously developed SNPseeker
algorithm allows the detection of single nucleotide substitutions
in large pooled samples (Druley et al. 2009), but still fails to address
two important key challenges in rare variant detection.
First, presently no algorithm has been able to detect indels in
pools larger than 42 individuals without the presence of many
false-positives (;40%) (Koboldt et al. 2009), despite the fact that
they account for one-quarter of the known mutations implicated
in Mendelian diseases (Ng et al. 2008; Stenson et al. 2009). In
particular, short indels represent the most common type of this
class of variation (Ng et al. 2008) and have been reported to oc-
cur as rare germline variants associatedwith genetic diseases such
as breast and ovarian cancer (King et al. 2003). Efforts to detect
disease-associated genetic variants will therefore greatly benefit
from the ability to accurately detect rare short indels.
Second, in order to accurately detect rare variants in a large
pooled sample, an optimal significance cutoff for the accurate
discrimination of true variants from false-positives must be cho-
sen. This parameter is, in practice, affected by sequencing error
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rates and average coverage, which have been shown to change for
every run (Druley et al. 2009). Failure to define an optimal cutoff
results in lower sensitivity and increased false-positive rates. Since
the rare variant hypothesis posits that individual disease-associ-
atedmutations will be extremely rare (but cumulatively common),
it is absolutely critical to be able to specifically discriminate, in
every experiment, a single heterozygous individual in a large co-
hort from the background noise. Until now this has not been re-
liably demonstrated.
To address these important challenges, we have developed
a novel experimental and computational strategy that combines a
synthetically engineered DNA library inserted in each run and a
new computational approach named SPLINTER (short indel pre-
diction by large deviation inference and nonlinear true frequency
estimation by recursion). This approach allows accurate detection
and quantification of short insertions, deletions, and substitutions
by integrating information from the synthetic DNA library to tune
SPLINTER and quantify specificity and sensitivity for every ex-
periment in order to accurately detect and quantify indels and
substitutions (Fig. 1; Supplemental Fig. 1).
SPLINTER requires the presence of two components: a neg-
ative control (1–2 kb of cloned plasmid DNA) used to generate a
run-specific error model, and a positive control consisting of
a synthetic DNA library simulating an artificial pool with muta-
tions engineered at a known position and frequency. We tested
SPLINTER on synthetically engineered pooled samples containing
differentmutations at different frequencies in a variety of sequence-
context backgrounds, obtaining 100% sensitivity with no false-
positives in pools up to 500 individuals. SPLINTER was also able to
accurately quantify allele frequencies—predicted and observed al-
lele frequencies were correlated with a correlation of 0.999.We find
that SPLINTER significantly outperforms all of the other algorithms
for the analysis of pooled sequencing data by being the most sen-
sitive approach, while also returning almost no false-positives. We
then applied our strategy to multiple pooled samples, identifying
novel and already described sequence variants, all of which were
independently validated.
Results
Detection of rare insertions and deletions in synthetic libraries
For each experiment, we first pooled equimolar amounts of sample
DNA together with the controls and generated a DNA library to be
sequenced on the Illumina Genome Analyzer IIx sequencing
platform. We then mapped back the sequencing reads to their
reference and built a run-specific error model from the negative
control reads. Next, we optimized our cutoff parameters on the
positive control and then called SNPs and indels on our sample (see
Supplemental material). We first sought to determine the upper
Figure 1. Experimental and computational pipeline for detection of indels and substitutions in large pooled DNA samples: DNA samples from a se-
lected group of patients are individually pooled in a complex mixture to be used as a template for PCR amplification of selected genomic loci. The pool
PCR products are then combined in an equimolar mix containing a DNA fragment without variants (negative control) and a synthetic pool with engi-
neered mutations present at the lowest expected variant frequency present in the sample (positive control). The mix is then sequenced on Illumina
Genome Analyzer LIX, and sequencing reads are mapped back to the sample and the controls reference sequence by gapped alignment. The negative
control reads are used to generate a second-order error model to be used in the variant calling phase. The positive control allows determination of the
optimal cutoff for maximizing specificity and sensitivity of the analysis. SPLINTER will then be used to analyze the pooled sample, resulting in detection
and quantification of indels and substitutions present in the pool. The SPLINTER algorithm detects true segregated variants by comparing the frequency
vector of observed read bases to an expected frequency vector defined by the error model. If the observed vector is significantly different from the
expected vector, then SPLINTER will call that position a sequence variant. For each identified variant, SPLINTER will then perform maximum likelihood fit
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limit of the number of samples that SPLINTER can analyze in
a pool. To do so, we generated three synthetic DNA libraries, each
containing 15 different indels and substitutions (Supplemental
Tables 1, 2; Supplemental material) introduced at frequencies of
0.005, 0.002, and 0.001, respectively (corresponding to cohorts of
100, 250, and 500 diploid individuals). We sequenced these li-
braries using the workflow shown in Figure 1. In each instance,
SPLINTER was able to correctly identify every variant (15/15 vari-
ants) without making false-positive calls (2254/2254 true-nega-
tives) (Fig. 3A, below; Supplemental Table 4). We concluded that
SPLINTER can accurately and reliably detect single heterozygous
mutations in pools of up to 500 individuals.
Estimation of required sequencing coverage for optimal indel
and substitution detection
We next investigated how SPLINTER’s accuracy changed as
a function of average sequencing coverage. To do so, we sampled
the sequencing data obtained for each of the three previous li-
braries at different fractions (Supplemental material) and then
computed the accuracy of our predictions in the form of an area
under a receiver-operator curve (AUC), a commonly usedmetric of
accuracy ranging from 0.5 (random guessing) to 1 (100% sensi-
tivity and specificity). By plotting AUC as a function of average
sequencing coverage we found that accuracy increased with cov-
erage, with high-frequency variants requiring less coverage than
lower-frequency variants (Fig. 2A). By analyzing AUC as a function
of coverage per allele, we observed a clear overlap of the curves for
each pool, reaching AUC equal to 1 at ;30-fold average coverage
per haploid genome (Fig. 2B), indicating that accurate detection
can be achieved given enough coverage independently of pool
size.
Recent resequencing efforts show that indel detection re-
mains challenging, as their false-positive rate is 15-fold higher
than substitutions (Pleasance et al. 2010). Our initial data sug-
gested that indels can be detected as sensitively and accurately as
substitutions. To test this hypothesis, we generated five additional
DNA libraries with synthetic insertions, deletions, and substitu-
tions included at a wide range of frequencies (from one to 50
variants in 1000 total alleles) (Supplemental Tables 2, 4). We
achieved 100% sensitivity for all of the pools (9/9 indel variants
and 10/10 substitution variants) with specificities between 99.91%
and 100% (between 2263/2265 and 2259/2259 true-negatives).
We then plotted the relationship between AUC and coverage for
Figure 2. Relationship between variant detection accuracy and average sequencing coverage per base. (A) Accuracy expressed as AUC (area under the
curve) (y-axis) plotted as a function of average sequencing coverage per base (x-axis) for synthetic pools with variants present at frequencies 1/200, 1/500,
and 1/1000. (B) Same as in A, with average sequencing coverage per base per allele on the x-axis. (C–E ) AUC (y-axis) as a function of average sequencing
coverage per base (x-axis) for insertions (C ), deletions (D), and substitutions (E ). Variants are present at frequencies 1/1000, 5/1000, 10/1000, 15/1000,
and 50/1000.
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each set. Indels converged to AUC equal to 1 at a rate comparable
to substitutions independently of the frequency of the mutation
(Fig. 2A–C). Thus, we conclude that SPLINTER detects indels as
accurately and as sensitively as it does substitutions.
Since many deleterious indels are 4 bp or shorter (King et al.
2003; Ng et al. 2008), we wanted to determine whether SPLINTER
could accurately detect indels as large as 4 bp. We generated and
sequenced two synthetic pools containing eight and 10 4-bp indels
with frequencies ranging from 0.001 to 0.020 and from 0.025 to
0.045, respectively. SPLINTER achieved 100% sensitivity 10/10
variants and 100% specificity (2253/2253 true-negatives) for allele
frequencies between 0.025 and 0.045 and 100% sensitivity (8/8
variants) and99.5% specificity (2243/2253 true-negatives) between
0.001 and 0.020 (Supplemental Tables 3, 4). These results suggest
that SPLINTER is sensitive and specific in detecting 4-bp indels.
Comparison of SPLINTER with other variant
discovery approaches
We next compared SPLINTER with existing tools for variant call-
ing. We used the synthetic DNA libraries previously described to
benchmark the sensitivity and positive predictive value of each
method. We compared SPLINTER with SNPseeker (Druley et al.
2009), MAQ (Li et al. 2008), SAMtools (Li et al. 2009), and VarScan
(Koboldt et al. 2009) for the detection of substitutions (Fig. 3A,B)
and with SAMtools and VarScan for the detection of indels (Fig.
3C,D). For each data set analyzed, SPLINTER significantly out-
performed every other approach. In all of the synthetic libraries
containing substitutions, SPLINTER detected all of the synthetic
variants with no false-positives, thus achieving a 100% sensitivity
and specificity. SNPseeker also achieved perfect accuracy in the
pool simulating 100 individuals, but had a 20% positive predictive
value in the libraries simulating 250 and 500 individuals, and had
only an 80% sensitivity in the 500 individual library. The other
approaches detected variants with substantially lower sensitivity
and positive predictive values in all libraries. For each indel set,
SPLINTER returned all of the true variants with no false-positives,
except for the indel 1 set and the 4-bp 1 set (;30% and ;50%
positive predictive values, respectively). In comparison, every other
approach resulted in false-positive rates greater than 80%, while
achieving low sensitivity, with the exception of the second 4-bp
set. We also compared SPLINTER with a recently published new
algorithm for pooled DNA variant detection called CRISP (Vikas
2010) for both substitution and indel detection (Supplemental Fig.
2). SPLINTER outperformedCRISP in both sensitivity (atmost 40%
increment) and positive predictive value (at most 80% increment).
In order to distinguish whether the improved accuracy in
variant finding originated from improved alignments or improved
variant calling, we also compared the performance of SPLINTER
using our alignment algorithm versus using reads aligned with
Figure 3. Comparison between SPLINTER and other variant calling algorithms: Substitutions (A,B) and indels (C,D) were analyzed independently. For
each approach, performance was evaluated by assessing sensitivity (fraction of true-positive hits divided by total positives in the set) and positive predictive
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Novoalign (http://www.novocraft.com). Both aligners resulted in
a comparable performance in finding true variants (Supplemental
Fig. 3), although our aligner showed small increases in sensitivity
and positive predictive value in several of the analyzed pools. This
result suggests that improved variant calling accuracy mostly
depended on the variant calling algorithm and not the underlying
aligner. Taken together, there results demonstrate that SPLINTER
outperforms other approaches at detecting single nucleotide sub-
stitutions and indels in large pools.
Estimation of the frequency of rare insertions and deletions
in synthetic libraries
Having established that SPLINTER could detect rare variants in
pooled samples, we next examined whether SPLINTER could also
accurately determine the frequencies of the identified variants.We
compared estimated and expected indel frequencies from all of our
libraries (frequency range 0.001 ; 0.050) and found a very high
correlation (r = 0.969, P < 2.2 3 1016; Fig. 4A), indicating that
SPLINTER was able to accurately estimate allele frequencies. We
next sought to better understand the causes of the observed errors
in our allele frequency estimates. Allele quantification can be af-
fected by pipetting errors during DNA pooling and by preferential
amplification of specific alleles in the pooled PCR. To distinguish
between these two sources of error, we constructed all of our
plasmids so that each contained two mutations spaced far enough
apart to be analyzed independently (i.e., with no overlapping
reads). If pipetting error and amplification bias are the major
sources of error in allele quantification, then the estimated allele
frequencies of mutations on the same plasmid will be highly cor-
related. This was indeed the case. Frequency estimates for muta-
tions within the same molecule were very highly correlated (r =
0.995, P < 2.2 3 1016; Fig. 4C), indicating that most of the noise
in variant quantification was due to experimental error. We simi-
larly observed very high correlations with substitutions (fre-
quency correlation r = 0.956, P < 2.2 3 1016; pair correlation r =
0.993, P < 2.2 3 1016; Fig. 4D) and 4-bp indels (frequency corre-
lation r = 0.962, P = 1.5013 1011; pair correlation r = 0.939, P =
5.599 3 105) (Supplemental Fig. 4). Based on these results, we
reasoned that robotic pooling of samples might improve allelic
quantification. Therefore, we robotically pooled and sequenced a
large cohort of 974 people previously analyzed in a GWA study (see
Methods). As expected, we observed an almost perfect correlation
(r = 0.999, P < 2.2 3 1016; Fig. 4E) between the GWA frequencies
and the frequencies estimated by SPLINTER, indicating that in-
accurate pipetting was indeed a primary source of error.
Figure 4. Precise quantification of rare genetic variants in synthetic and real samples. (A,B) Correlation between variant frequency measured by
SPLINTER (y-axis) and expected variant frequency (x-axis) from eight synthetic pools for indels (A) and substitutions (B). (C,D) Pair correlation between
mutation pairs present in the same DNA molecule for indels (C ) and substitutions (D). (E) Correlation between variant frequency measured from GWA
study (x-axis) and SPLINTER estimated frequency (y-axis).
High-throughput discovery of rare indels
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High-throughput discovery of rare indels in large
patient cohorts
Finally, we applied SPLINTER to a large human cohort as a ‘‘real-
world’’ test of the algorithm. We sequenced 14 loci (2596 bp total)
in 1152 individuals, which were divided into nine pools (94–178
individuals per pool) (see Methods). For every sequenced pool, we
included a negative and positive control to tune SPLINTER. We
identified, on average, 19 variants per pool (for a total of 151 var-
iants, see Supplemental Table 6). To confirm SPLINTER’s accuracy,
we examined the overlap of our hits with variants listed in dbSNP.
We observed large overlapping fractions—between 68.5% and
100% of the identified variants in each pool could be found in
dbSNP (Supplemental Tables 5, 6). In all cases, statistical signifi-
cance was reached (Fisher’s exact test; Supplemental Table 5). We
selected 14 variants (three novel variants and 11 fromdbSNP) from
the largest analyzed pool for independent validation by individual
genotyping using the Sequenom iPLEX platform. All 14 variants
were confirmed, resulting in 100% positive predictive value. Fur-
thermore, allele frequencies were highly correlated with those es-
timated by SPLINTER (r = 0.985, P = 5.958 3 109; Supplemental
Table 8; Supplemental Fig. 5). Together, these results demonstrate
the utility of the SPLINTER methodology for the rapid analysis of
large populations of individuals. All of the computational tools,
source codes, and the experimental datasets presented in this study
can be accessed at http://cgs.wustl.edu/;fvallania/4_splinter_
2010/5_splinter_webpage/SPLINTER_supporting_material.html.
Discussion
Rare genetic variation is likely to describe a substantial portion
of heterogeneity in common and complex diseases. Identifying
disease-associated rare variants requires the analysis of multiple
loci in large cohorts. We have shown that a novel experimental
design combined with SPLINTER can accurately identify genetic
variants in large pools, leading to several advantages over other
computational strategies.
First, we found that SPLINTER identified genetic variantswith
high sensitivity and precision, whereas the other methods were
unable to detect a large fraction of the variation present in the
samples. We found that a sequencing coverage of ;303 per hap-
loid genomewas required to detectmutationswithhigh sensitivity
and specificity. In earlier work, we successfully analyzed pooled
samples using SNPseeker at lower sequencing coverage (;13.8-fold
per haploid genome) (Druley et al. 2009). However, in that study
most of the variants were present in many individuals in the pool,
suggesting that in order to detect singleton alleles with ;100%
confidence in a variety of different sequence contexts a higher
sequence coverage is required. This finding is confirmed by re-
cent resequencing studies of single cancer genomes, where near-
optimal accuracy of somatic SNP detection (3% false discovery
rate) was achieved at ;40-fold average haploid genome coverage
(Pleasance et al. 2010), and by the lower performance of SNPseeker
when compared with SPLINTER in detecting substitutions present
at one in a 1000 in both sensitivity and precision.
Second, our strategy incorporates a synthetic positive control
and a negative control, which allow estimation of sensitivity and
specificity for each experiment. This is important because run-to-
run variations in sequencing error rates can influence accuracy and
perturb the optimal P-value cutoffs. The inclusion of the control
DNA has a negligible impact on experiment cost. One single-end
sequencing lane (;30 million 36-bp-long reads per lane) can
provide enough coverage to analyze ;25 kb of genomic DNA in
500 patients, with the control sequences accounting for ;4% of
the total sequencing data.
Third, SPLINTER can accurately and sensitively detect indels
with a high sensitivity and accuracy. Detection of indels, even in
single genome resequencing studies, is indeed a challenging prob-
lem due to the difficulties in reducing the false-positive rate while
retaining good sensitivity (Pleasance et al. 2010). In addition, pre-
viously published approaches cannot detect indels (Li et al. 2008;
Druley et al. 2009), or can only be applied to small-sized cohorts
(42 people) (Koboldt et al. 2009). Together, these issues have lim-
ited the application of pooled DNA sequencing. We have shown
here that SPLINTER can accurately discriminate single indels in
pools as large as 500 individuals with high sensitivity and speci-
ficity. By comparison, the best performing algorithm achieved at
best an 80% false-positive rate.
Fourth, SPLINTER can accurately quantify the frequency of
the alleles present in the pool. Althoughhigh correlations between
real and estimated frequencies were observed, small discrepancies
may result in errors in variant association to a phenotype if the
variant is rare and the effect of the variant is high. Our pair cor-
relation analysis shows that the major source of errors in quanti-
fication does not come from SPLINTER, but rather from pipetting
errors in pool construction as indicated by the improved correla-
tions after robotic pipetting of the pools. This issue can, in fact, be
resolved by performing orthogonal validation of the samples,
which will be highly facilitated by the overall performance of
SPLINTER in detecting rare variants as opposed to other methods.
In contrast, the major source of error in array-based pooled DNA
analysis is array variation, being seven times higher than pool
construction variation (Macgregor 2007). This observation argues
that our approach shows even higher accuracy compared with
other experimental platforms.
Finally, our approach can be applied to any pooled cohort or
anyheterogeneous sample of any size and can be easily scaled up to
whole-exome and whole-genome analysis. Given the presence of
a positive control to infer the optimal parameters, pooled samples
can accurately be analyzed without limitations on experimental
design or achieved coverage. In this study, we used PCR to amplify
the various genomic regions, but our strategy is also compatiblewith
solid and liquid-phase genomic capture approaches (Mamanova
et al. 2010).
We found that alignment errors decreased our ability to detect
large indels. This explains why SPLINTER performed slightly worse
in the analysis of the 4-bp indel libraries relative to the 1–2-bp
indel libraries. To detect the longer indels, it was necessary to allow
larger gaps in our read alignments, which increased the overall
alignment noise. We believe this was due to potential sequencing
artifacts or sample contaminants aligning back to the reference
sequence, thereby reducing the signal coming from true variants.
This limitation can be overcome with longer sequencing read
lengths, which should reduce the ambiguity in aligning reads while
allowing larger gaps (in this work, all sequencing reads were 36 bp
in length). Similarly, while whole-genome analysis may present
additional challenges due to increased sequence complexity, com-
pared with the analyzed synthetic controls we expect it to mostly
impact the read alignment step in the analysis pipeline, which can
be overcome by generating paired-end and/or longer sequencing
reads. In addition, with reduced error rate, fewer observations at
a given variant positionwill be needed to provide confidence in the
variant call. Nevertheless, our approach is the first one to accurately
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One departure of our algorithm from other variant calling
programs is that SPLINTER does not incorporate quality scores in
any step of the analysis. We have found that our error model
captures essentially the same information that is contained in
quality scores (see Supplementalmaterial; Druley et al. 2009 and so
including quality score information does not improve SPLINTER’s
performance. The highperformance of ourmethod comparedwith
others that use quality scores (Li et al. 2008; Koboldt et al. 2009)
suggests that this viewpoint is likely correct. Additionally, ana-
lyzing reads aligned with quality scores resulted in equal or lower
performance when compared with reads aligned using our aligner
(see Supplemental Fig. 5).
To obtain a complete understanding of the molecular causes
of common diseases, it is critical to be able to detect and analyze
rare variants (Van Tassel et al. 2008; Druley et al. 2009; Erlich et al.
2009; Koboldt et al. 2009; Prabhu and Pe’er 2009). Pooled DNA
sequencing is an important method for rare variant analysis, since
it enables the rapid and cost-effective analysis of thousand or tens
of thousands of individuals. SPLINTER will also be useful for ana-
lyzing samples that are naturally heterogeneous—e.g., for the de-
tection and quantification of rare somatic mutations in tumor
samples (Stingl and Caldas 2007). A second promising application
is detection of induced mutations in in vitro evolution experi-
ments (Barrick at al. 2009; Beaumont et al. 2009). Thus, we expect
SPLINTER will become a useful tool for the analysis of data gen-
erated by next-generation sequencing methods.
Methods
Preparation of the synthetic pools
Every synthetic pool library consists of a mixture of different oli-
gonucleotides, where one is referred to as the wild-type allele and
the others are mutants with respect to the wild type. We used the
consensus sequence of the 72-bp exon 9 from TP53 (RefSeq ac-
cession no. NM_000546) as the ‘‘wild-type’’ insert into a pGEM-T
Easy vector (Promega). We then designed a panel of different var-
iations of this consensus sequence (see Supplemental Tables 1–3)
containing single, double, and 4-bp indels, as well as single nu-
cleotide substitutions. These vectors could then be pooled such
that each mutation was present at different frequencies. Once
pooled, a single PCR reaction was performed using primers that
flanked the insertion site and generated a 335-bp amplicon. To
facilitate ligation into the vector, each oligonucleotide was ordered
with 59 phosphorylation and an overhanging 39 A from Integrated
DNA Technologies. Complimentary oligonucleotide pairs were
annealed as follows: 1 mL of sense and antisense oligonucleotide at
100 mM were mixed with 5 mL of 103 PCR buffer (Sigma-Aldrich)
and brought to a final volume of 50 mL. The annealing mix was
then warmed up to 95°C for 5 min, followed by 20 min at 25°C.
Each annealed sequence was then ligated into the pGEM-T Easy
Vector (Promega) according to the manufacturer’s protocol and
reagents. The final ligation productwas then transformed intoGC-
10 competent cells (GeneChoice) using standard cloning protocol.
Colonies were screened using ‘‘Blue/White’’ selection induced by
Xgal and IPTG, White colonies were picked and grown on Luria
broth agar with ampicillin for 12–16 h. Plasmidwas then recovered
from the transformed bacteria suspension using Qiaprep Spin
Miniprep kit according to the manufacturer’s protocol (Qiagen).
Following insert validation by Sanger sequencing, plasmid pools
were prepared by pooling each plasmid at the appropriate number
of molecules in order to introduce the desired mutations at the
desired frequency with respect to the wild-type background. Each
pool was generatedwith a total number of 1011 plasmidmolecules.
This was chosen in order to mimic the best conditions described
in the original pooled-DNA sequencing protocol11 to maximize
the number of molecules available for analysis, while keeping
fluid volumes tractable. Each pool was then PCR amplified using
primer sequences flanking the plasmid insertion site (see Supple-
mental Table 4). Each PCR reaction was performed as follows:
(1) 93°C for 2 min; (2) 93°C for 30 sec; (3) 56°C for 30 sec; (4) 65°C
for 2 min; (5) repeat steps 2–4 for 18 cycles; (6) 65°C for 10 min.
Each PCR mix contained 2.5 uL of 103 PfuUltra buffer, 10 mM
forward and reverse primers, 1 M betaine (Sigma-Aldrich/Fluka),
1.25 U PfuUltra DNA polymerase, and between 30 and 50 ng of
template DNA in a final volume of 25 uL. Each pool was then se-
quenced using a single lane of the Illumina Genome Analyzer II
platform.
DNA library preparation and sequencing for pooled samples
After PCR amplification of target loci, a second pool was created by
adding PCR products to the positive and negative controls for the
analyzed pooled sample. In order to generate uniform sequencing
coverage, every PCR product and control was pooled at the same
number of molecules (chosen to be at least 1011 molecules [;1 mg]
in order to have enough material for the sequencing library prep-
aration). Random ligation, sonication, and sequencing library
preparation were performed as previously described with a few
changes. DNA ligation was performed in a final volume of 50 mL.
Prior to sonication, ligation products were diluted 1:10 using
Qiagen PBI buffer from the QIAquick PCR Purification Kit (Qia-
gen). Fragmentation was then performed using the Bioruptor XL
sonicator (Diagenode). Samples were sonicated in parallel with the
following settings: 25 min of total sonication time, 40 sec of pulse
followed by 20 sec without pulse, high power pulse setting. This
resulted in each pool of large concatemers being randomly frag-
mented between 500 and 4000 bp (data not shown). Following
sonication, DNA samples were then purified via the QIAquick PCR
purification kit (Qiagen) and sequencing libraries were prepared
according to the standard protocol for genomic sample prepara-
tion by Illumina (Illumina). Each library was then sequenced on
a single lane of an Illumina Genome Analyzer II, generating 36-bp
read lengths.
Variant calling in pooled samples
For each pooled sample, reads were compressed in order to reduce
computational run-time and then aligned to their reference using
a dynamic programming algorithm (see Supplemental material).
Aligned readswere used to generate a run-specific errormodel from
the incorporated negative control. The aligned file and the error
model are thenused by SPLINTER in input to detect the presence of
a sequence variant in the pool at any analyzed position. Optimal
detection of true variants was achieved by calibrating the P-value
cutoff used by SPLINTER with information generated from the
included positive control (see Supplemental material).
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